Tighter regulation of puberty blockers for gender-affirming care is being considered by the Ministry of Health at the behest of the Coalition Government
Researchers who detected a sharp reduction in New Zealand’s high rate of prescribing puberty blocking drugs for gender dysphoria in young people speculate that growing caution overseas may be a factor
Academic pharmacist Nataly Martini provides key information on Helicobacter pylori pathophysiology, diagnosis and evidence-based treatment strategies to enhance patient outcomes